Form 4: Quest Diagnostics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Mark A. Gardner, SVP of Molecular Gen & Oncol at Quest Diagnostics, disposed of 120 shares of common stock to cover tax withholding obligations.
Summary
- On September 24, 2024, Mark A. Gardner, SVP of Molecular Gen & Oncol at Quest Diagnostics, disposed of 120 shares of common stock.
- The transaction was executed to cover tax withholding obligations arising from the vesting of restricted share units.
- The price per share was $155.7.
- Following the transaction, Gardner beneficially owns 4,673 shares of Quest Diagnostics common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a routine transaction to cover tax obligations. It doesn't indicate any positive or negative outlook for the company.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are often related to compensation and tax planning. These transactions are closely monitored by investors for insights into management's perspective on the company's value and future prospects.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a small sale of shares by an executive for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 09/24/2024 | Date of transaction: Mark A. Gardner disposed of shares. |
| 09/26/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.